行业一季报的情况已经明显好于预期，20 年疫情受损公司，今年一季度增长基本是翻倍
以上，相比19 年也有40 以上增长是比较常态的情况，下周大会密集，新产品高发，催化剂多样化。智能化应用拓宽安防外的应用场景，行业空间规模化放大，某种程度上看，海康的增长实际上反映了我国的企业数字化转型的进展。

工业互联网进入规模化扩张窗口期，“5G+工业互联网”面临三个挑战。无人驾驶板块利好政策加持智能驾驶加速发展，9只智能驾驶概念股2020年净利润增幅翻倍。互联网医疗企业上市潮起，在线医疗服务的需求猛增。

The recent technological advancements in the field of next-generation sequencing (NGS) and cell and molecular biology have given birth to a new era of precision medicine, giving a platform to analyze the variability in genes, lifestyle, and environment of each person individually. Now, the researchers have found an even better option of gene expression analysis through single-cell sequencing, which precedes the advancements of next-generation sequencing. In the past few decades, whole genome sequencing (WGS) and whole transcriptome sequencing (WTS) methods have been applied to single cells to combine DNA, RNA, protein, and chromatin information through a single cell. The multi-omics technique has enabled researchers to use genomics, proteomics, transcriptomics, and epigenomic to understand the heterogeneity of genetically identical cells in the same tissue. Single-cell sequencing has been able to portray a clear picture of functions of each specific cell by combining multiple layers of information at a single-cell resolution, analyzing both DNA and RNA to understand single-cell genome or chromatin and transcriptome and proteome data, respectively.

The report provides market dynamics and estimation, trends, and forecast related to the global proteomics market. Proteomics is the large-scale study of proteins. The revenue generated through the sale of proteomics instruments, reagents, and services is considered in the scope of the current report. However, revenue associated with related technologies such as transcriptomics and genomics are not considered in the report.

Single-use systems refer to disposable equipment and related consumables, which are designed to be used once and then discarded. Generally, they are composed of plastic components, which are sterilized and sealed using gamma irradiation. They eliminate the need for cleaning, validation, and sterilization before use as they come sterile. They also avoid water for injection (WFI), steam in place (SIP), clean in place (CIP) throughout the biomanufacturing facilities. In their purest form, single-use systems are replacing stainless steel or glass with plastic products. They have become well-accepted technology among biopharmaceutical manufacturers in a relatively short time, especially for clinical research and pre-commercial drug development activities. These disposable devices and components have created new segments in the bioprocessing industry that have been evolving over the past few years. Several biopharma companies are adopting this technology for its ease and the flexibility that it offers in adjusting to varying product supply and demand.